drugset / Trial / NCT00003974
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
Treatment
Summary
RATIONALE: Vaccines made from a person's tumor may help the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have undergone surgery to remove stage I, stage II, or stage IIIA non-small cell lung cancer or stage I or stage II mesothelioma.
Timeline
- Start
- 1997-08
- Primary completion
- 1998-06
- Completion
- 2000-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | lung tumor associated antigen | Unknown | — | Other |
| Background | Cyclophosphamide | Other / unclassified | — | Intravenous |
| Background | DetoxPC | Unknown | — | Other |